Compare DraftKings Inc (DKNG) vs 10X Genomics Inc (TXG) Price & Performance

DraftKings IncTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs 10X Genomics Inc — how do they compare? DraftKings Inc trades at $25.21 (market cap $12.05B), while 10X Genomics Inc trades at $58.6 (market cap $7.64B). The key difference: DraftKings Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.

	DKNG	TXG
Market Cap	$12.05B	$7.64B
Sector	Consumer Cyclical	Health
52-Week High	$48.23	$58.57
52-Week Low	$20.72	$11.34
Enterprise Value	$12.98B	$7.17B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DraftKings Inc

No Aura AI signal available yet.

10X Genomics Inc

TXG is trading at $52.03, up 14.1% in the past 24 hours, reflecting strong momentum. The stock exhibits a bullish technical signal with moving averages supporting upward trends, while RSI levels suggest mild overbought conditions. Fundamentally, the company reported Q2 2026 revenue of $151 million, beating estimates, and has shown consistent earnings beats in recent quarters. Recent news highlights collaborations with Cleveland Clinic and the acquisition of Proteintech Genomics, expanding its multiomics capabilities and reinforcing growth prospects.

The outlook for TXG is cautiously optimistic, driven by earnings outperformance and strategic expansions, but risks include persistent net losses and high valuation multiples. Analyst consensus is mixed with a $46 price target, indicating potential downside from current levels. Investors should weigh revenue growth against profitability challenges and monitor execution on new initiatives for sustained upside.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings faces decline as prediction markets outpace traditional sportsbooks, shares down 30% YTD.Seeking Alpha · 1 day agoBearish DraftKings Q2 misses earnings but shows strong growth in Predictions platform, stock remains a hold ahead of NFL season.24/7 Wall Street · 1 day agoNeutral DraftKings' prediction markets drive rapid growth, reshaping its national sports betting strategy.PYMNTS · 4 days agoBullish View details →

TXG

View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.